Boatman, J. A., Baker, J. V., Emery, S., Furrer, H., Mushatt, D. M., Sedlacek, D., . . . Neaton, J. D. (2019). Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 cells/mm(3): Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial. J Acquir Immune Defic Syndr.

Boatman, Jeffrey A., Jason V. Baker, Sean Emery, Hansjakob Furrer, David M. Mushatt, Dalibor Sedlacek, Jens D. Lundgren, and James D. Neaton. "Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm(3): Findings From the Strategic Timing of AntiRetroviral Treatment (START) Trial." J Acquir Immune Defic Syndr 2019.

Boatman, Jeffrey A., et al. "Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm(3): Findings From the Strategic Timing of AntiRetroviral Treatment (START) Trial." J Acquir Immune Defic Syndr 2019.